Highlights from Singapore on Immunotherapies in Early-Stage NSCLC
Host: Charu Aggarwal, MD, MPH
\n\n Host: Patrick Forde, M.B.B.Ch.
\n\n\n \n
The treatment options for non-small cell lung cancer (NSCLC) are constantly evolving, making it challenging for healthcare professionals to stay updated with the latest scientific evidence. This program aims to address this challenge by bringing together esteemed faculty members who will discuss pivotal scientific advances and practice-altering information related to the use of systemic immunotherapy, targeted therapies, and perioperative immunotherapy in the management of NSCLC across all disease stages.